Rosado J, Pelleau S, Cockram C et al. Multiplex assays for the identification of serological signatures of SARS-CoV-2 infection: an antibody-based diagnostic and machine learning study. The Lancet Microbe 2021; doi: 10.1016/S2666-5247(20)30197-X.

Bertoglio F, Meier D, Langreder N et al. SARS-CoV-2 neutralizing human recombinant antibodies selected from –pre-pandemic healthy donors binding at RBD-ACE2 interface. Nature Communications 2021; doi: 10.1038/s41467-021-21609-2.

Sahin U, Muik A, Derhovnessian E et al. COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell repsonses. Nature 2020; doi: 10.1038/s41586-020-2814-7.

Tian J-H, Patel N, Haupt R et al. SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice. Nature Communications 2021; doi: 10.1038/s41467-020-20653-8.

Routhu NK, Cheedarla N, Gangadhara S et al. A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs. Immunity 2021; doi: 10.1016/j.immuni.2021.02.001.

Gai J, Ma L, Li G et al. A potent neutralizing nanobody against SARS-CoV-2 with inhaled delivery potential. MedComm 2021; doi: 10.1002/mco2.60.

Hicks J, Klumpp-Thomas C, Kalish H et al. Serologic Cross-Reactivity of SARS-CoV-2 with Endemic and Seasonal Betacoronaviruses. Journal of Clinical Immunology. 2021. doi: https://doi.org/10.1007/s10875-021-00997-6

Klassan SA, Senefeld, JW, Johnson PW et al. The Effect of Convalescent Plasma Therapy on COVID-19 Patient Mortality: Systematic Review and Meta-analysis. medRxiv 2021; doi: 10.1101/2020.07.29.20162917.

Xiao T, Wang Y, Yuan J et al. Early Viral Clearance and Antibody Kinetics of COVID-19 Among Asymptomatic Carriers. Frontiers in Medicine. 2021. doi:https://doi.org/10.3389/fmed.2021.595773

Gontu A, Srinivasan S, Salazar E et al. Limited window for donation of convalescent plasma with high live-virus neutralizing antibodies for COVID-19 immunotherapy. Communications Biology 2021; doi: 10.1038/s42003-021-01813-y.

Iyer AS, Jones FK, Nodoushania A et al. Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients. Sci Immunol 2020; doi:10.1126/sciimmunol.abe0367.

Patricio R Estevez-Soto. (2020, November 24). I’m really surprised to see a lot of academics sharing their working papers/pre-prints from cloud drives (i.e. @Dropbox @googledrive) 🚨Don’t!🚨 Use @socarxiv @SSRN @ZENODO_ORG, @OSFramework, @arxiv (+ other) instead. They offer persisent DOIs and are indexed by Google scholar [Tweet]. @prestevez. https://twitter.com/prestevez/status/1331029547811213316

Thinking of a personal site as a pre-print server is an interesting concept and somewhat similar to the idea of a commonplace book.

‘OSF: A Project Management Service Built for Research - ROpenSci - Open Tools for Open Science’. Accessed 10 August 2020. https://ropensci.org/blog/2020/08/04/osf/.

Santangelo, G. (2020, April 15). New NIH Resource to Analyze COVID-19 Literature: The COVID-19 Portfolio Tool. NIH Extramural Nexus. https://nexus.od.nih.gov/all/2020/04/15/new-nih-resource-to-analyze-covid-19-literature-the-covid-19-portfolio-tool/

Matias, J. N. (2020). Natematias/covid-19-social-science-research. https://github.com/natematias/covid-19-social-science-research (Original work published 2020)

Publons.com. (n.d.). Retrieved April 20, 2020, from https://publons.com/

This is just another, albeit specific, form of academic samizdat. https://indieweb.org/academic_samizdat

Interesting workflow and within his rights.